194 related articles for article (PubMed ID: 30518853)
1. Lecithin-Stabilized Polymeric Micelles (L
Chang CE; Hsieh CM; Huang SC; Su CY; Sheu MT; Ho HO
Sci Rep; 2018 Dec; 8(1):17640. PubMed ID: 30518853
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
3. Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity.
Cheng WJ; Lin SY; Chen M; Chen LC; Ho HO; Chuang KH; Sheu MT
Int J Nanomedicine; 2021; 16():4017-4030. PubMed ID: 34140769
[TBL] [Abstract][Full Text] [Related]
4. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo.
Cote B; Carlson LJ; Rao DA; Alani AWG
J Control Release; 2015 Sep; 213():128-133. PubMed ID: 26160305
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.
Xu G; Shi H; Ren L; Gou H; Gong D; Gao X; Huang N
Int J Nanomedicine; 2015; 10():2051-63. PubMed ID: 25844036
[TBL] [Abstract][Full Text] [Related]
6. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG
Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions.
Li H; Li M; Fu J; Ao H; Wang W; Wang X
Drug Deliv; 2021 Dec; 28(1):1226-1236. PubMed ID: 34142631
[TBL] [Abstract][Full Text] [Related]
9. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.
Yu J; Chen H; Jiang L; Wang J; Dai J; Wang J
J Pharm Sci; 2019 May; 108(5):1788-1799. PubMed ID: 30610857
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.
Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C
Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L
Su CY; Liu JJ; Ho YS; Huang YY; Chang VH; Liu DZ; Chen LC; Ho HO; Sheu MT
Eur J Pharm Biopharm; 2018 Feb; 123():9-19. PubMed ID: 29154834
[TBL] [Abstract][Full Text] [Related]
12. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it.
Li S; Yuan S; Zhao Q; Wang B; Wang X; Li K
Biomed Pharmacother; 2018 Apr; 100():441-447. PubMed ID: 29475141
[TBL] [Abstract][Full Text] [Related]
13. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles.
Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y
Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
15. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
Jain S; Jain AK; Pohekar M; Thanki K
Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
[TBL] [Abstract][Full Text] [Related]
16. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
[TBL] [Abstract][Full Text] [Related]
17. Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo.
Su CW; Chiang MY; Lin YL; Tsai NM; Chen YP; Li WM; Hsu CH; Chen SY
J Biomed Nanotechnol; 2016 May; 12(5):962-72. PubMed ID: 27305818
[TBL] [Abstract][Full Text] [Related]
18. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
19. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
20. Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.
Chen YC; Su CY; Jhan HJ; Ho HO; Sheu MT
Int J Nanomedicine; 2015; 10():7265-74. PubMed ID: 26664117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
